Quantcast

Latest Cephalosporin Stories

2014-09-05 08:23:38

- Potential Treatment For Patients With Complicated Urinary Tract Infections(cUTI) and Complicated Intra-Abdominal Infections (cIAI) - DUBLIN, Sept. 5, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that the U.S. Food and Drug Administration (FDA) has accepted for filing Actavis' application for ceftazidime-avibactam, its investigational antibiotic for the treatment of patients with Complicated Urinary Tract Infections (cUTI) and Complicated Intra-Abdominal Infections...

2014-08-19 08:29:39

DUBLIN, Aug. 19, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed positive topline results from RECLAIM-1 and -2, pivotal Phase III studies evaluating the potential for the investigational antibiotic, ceftazidime-avibactam as a treatment for adult hospitalized patients with complicated intra-abdominal infections. Logo - http://photos.prnewswire.com/prnh/20130124/NY47381LOGO Ceftazidime-avibactam consists of a cephalosporin (ceftazidime), an established treatment for...

2014-07-04 16:21:01

-- Purchase enhances cost-competitiveness, paves way for future development -- LAKE FOREST, Ill., July 4, 2014 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced it has completed the acquisition of an active pharmaceutical ingredient (API) manufacturing facility and an associated research and development (R&D) facility from Orchid Chemicals & Pharmaceuticals Ltd. (BSE: 524372, NSE:...

2012-02-09 18:21:57

Trends in other countries and emerging cephalosporin resistance signal likelihood of treatment failures Researchers are continuing to sound the alarm on the growing threat of multi-drug resistant gonorrhea in the United States, according to a Perspective commentary in the Feb. 9 issue of the New England Journal of Medicine. In July 2011, the U.S. Centers for Disease Control and Prevention released "Cephalosporin Susceptibility Among Neisseria gonorrhoeae Isolates - United States,...

2012-01-30 18:00:00

Cefixime is effective for infections of the middle ear (otitis media), tonsillitis, throat infections (pharyngitis), laryngitis, bronchitis, and pneumonia caused by susceptible bacteria. New report “Cefixime - Comprehensive patent search” worked out by Genericsweb has been recently published by Market Publishers Ltd. London, UK (PRWEB) January 30, 2012 Cefixime is a semi-synthetic (partially man-made), oral antibiotic in the cephalosporin family of antibiotics. The cephalosporin...


Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related